↓ Skip to main content

Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma

Overview of attention for article published in Frontiers in oncology, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma
Published in
Frontiers in oncology, November 2018
DOI 10.3389/fonc.2018.00508
Pubmed ID
Authors

Barbara Castella, Assunta Melaccio, Myriam Foglietta, Chiara Riganti, Massimo Massaia

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 19%
Student > Ph. D. Student 3 11%
Student > Master 3 11%
Student > Doctoral Student 3 11%
Other 2 7%
Other 3 11%
Unknown 8 30%
Readers by discipline Count As %
Immunology and Microbiology 7 26%
Medicine and Dentistry 6 22%
Nursing and Health Professions 3 11%
Biochemistry, Genetics and Molecular Biology 2 7%
Agricultural and Biological Sciences 1 4%
Other 0 0%
Unknown 8 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2018.
All research outputs
#19,954,338
of 25,385,509 outputs
Outputs from Frontiers in oncology
#9,328
of 22,432 outputs
Outputs of similar age
#269,027
of 365,313 outputs
Outputs of similar age from Frontiers in oncology
#113
of 257 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,432 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 365,313 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 257 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.